Pune, India -- (SBWIRE) -- 02/26/2020 -- The global contraceptive pills market size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period. High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market. Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs. The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas. To counter this, governments in many developing and underdeveloped countries are taking efforts to make these modern day medications more accessible and affordable to the rural populace. This will effectively accelerate the oral contraceptives market growth during the forecast period.

Request A Sample Copy - Contraceptive Pills Market Report

The report provides market analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product & service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
Key Features of Contraceptive Pills Market Report:
- Overview, Industry Life Cycle Analysis, Supply Chain Analysis
- Size, Trends, Growth Drivers, Constraints, SWOT Analysis, Forecast Analysis
- Competitive Landscapes: Market Share, Product Portfolio, New Product Launches, etc.
- Market attractiveness and Associated Growth Opportunities
- Strategic Growth Opportunities for the Existing and New Players
- Key Success Factors

Gain More Insights into the Contraceptive Pills Market Research Report

Increasing Popularity of Advanced Contraceptives to Propel the Market in North America
North America is slated to dominate the contraceptive pills market share, since the region generated USD 4.09 billion in revenue in 2018. The primary reason for this is the rising uptake of short-acting reversible contraceptives in the U.S. and patient-friendly reimbursement policies for oral birth-control pills. Europe will emerge as the second leading region in this market, led by France which has the highest birth rate in the region. Better reimbursement policies will also bode well for the market in Europe. Asia-Pacific will record the fastest growth owing to rising number of awareness drives conducted by the government and NGOs. In Latin America, the Middle East, and Africa, increasing presence of big pharmaceutical companies and growing literacy rates will drive the market in these regions.
Key Companies and Manufacturers Covered:
- Janssen Pharmaceutical Company
- Piramal Enterprises
- Allergan, plc
- Mylan N.V.
- Pfizer, Inc.
- Bayer AG
- Teva Pharmaceutical Industries
- HLL Lifecare Limited
- Merck & Co., Inc.
- Others

Have Any Query? Ask Our Research Experts

Exciting Opportunities Await Local and Regional Players in the Market
While big companies such as Bayer AG are benefiting owing to their well-established presence, smaller players operating at the local and regional level are also slowly gaining ground in this market. This is a result of launching of innovative products by these players along with certain capacity restrictions hounding the large players.

Detailed Table of Content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Fertility Statistics (2018)
4.2 Regulatory scenario for key countries
4.3 Recent industry developments such as mergers & acquisitions
4.4 Key Industry Trends
4.5 Government policies & their impact on contraceptives industry
4.6 New Product Launches
5. Global Contraceptive Pills Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Type
5.2.1 Combined Contraceptives (E+P)
5.2.2 Progestin-only Pills
5.3. Market Analysis, Insights and Forecast – By Distribution Channel
5.3.1 Hospital Pharmacy
5.3.2 Retail Pharmacy
5.3.3 Clinics
5.3.4 Online Channel
5.3.5 Public Channel & NGOs
5.3.6 Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1 North America
5.4.2 Europe
5.4.3 Asia pacific
5.4.4 Latin America
5.4.5 Middle East & Africa
6. North America Contraceptive Pills Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Type
6.2.1 Combined Contraceptives (E+P)
6.2.2 Progestin-only Pills
6.3. Market Analysis – By Distribution Channel
6.3.1 Hospital Pharmacy
6.3.2 Retail Pharmacy
6.3.3 Clinics
6.3.4 Online Channel
6.3.5 Public Channel & NGOs
6.3.6 Others
6.4. Market Analysis – By Country
6.4.1 U.S.
6.4.2 Canada
7. Europe Contraceptive Pills Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis – By Type
7.2.1 Combined Contraceptives (E+P)
7.2.2 Progestin-only Pills
7.3. Market Analysis – By Distribution Channel
7.3.1 Hospital Pharmacy
7.3.2 Retail Pharmacy
7.3.3 Clinics
7.3.4 Online Channel
7.3.5 Public Channel & NGOs
7.3.6 Others
7.4. Market Analysis – By Country/Sub-region
7.4.1 U.K.
7.4.2 Germany
7.4.3 France
7.4.4 Spain
7.4.5 Italy
7.4.6 Scandinavia
7.4.7 Rest of Europe
8. Asia pacific Contraceptive Pills Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis – By Type
8.2.1 Combined Contraceptives (E+P)
8.2.2 Progestin-only Pills
8.3. Market Analysis – By Distribution Channel
8.3.1 Hospital Pharmacy
8.3.2 Retail Pharmacy
8.3.3 Clinics
8.3.4 Online Channel
8.3.5 Public Channel & NGOs
8.3.6 Others
8.4. Market Analysis – By Country/Sub-region
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Southeast Asia
8.4.6 Rest of Asia Pacific
9. Latin America Contraceptive Pills Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis – By Type
9.2.1 Combined Contraceptives (E+P)
9.2.2 Progestin-only Pills
9.3. Market Analysis – By Distribution Channel
9.3.1 Hospital Pharmacy
9.3.2 Retail Pharmacy
9.3.3 Clinics
9.3.4 Online Channel
9.3.5 Public Channel & NGOs
9.3.6 Others
9.4. Market Analysis – By Country/Sub-region
9.4.1 Brazil
9.4.2 Mexico
9.4.3 Rest of Latin America
Continued...

Reasons to Purchase this Report:

- Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players.
- Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market's expansion.
- Market dynamics and opportunities for growth for players in the near future.
- Competitive landscape describing the market revenue shares of key players.
- Market segmentation analysis that deals with quantitative and qualitative research, discussing the influence of policy-based and economical aspects.

Our proven methodologies and systematic analysis help in making confident business and strategic decisions.
A market study that conducts at Fortune Business Insights can save significant cost and time, and can help prevent making costly mistakes.

Order Full Report

About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com